{
  "DOI": "10.1186/s40246-022-00411-1",
  "ISSN": [
    "1479-7364"
  ],
  "URL": "http://dx.doi.org/10.1186/s40246-022-00411-1",
  "abstract": "\u003cjats:title\u003eAbstract\u003c/jats:title\u003e\u003cjats:sec\u003e\u003cjats:title\u003eBackground\u003c/jats:title\u003e\u003cjats:p\u003eHuman angiotensin-converting enzyme 2 (ACE2), a type I transmembrane receptor physiologically acting as a carboxypeptidase enzyme within the renin-angiotensin system (RAS), is a critical mediator of infection by several severe acute respiratory syndrome (SARS) corona viruses. For instance, it has been demonstrated that ACE2 is the primary receptor for the SARS-CoV-2 entry to many human cells through binding to the viral spike S protein. Consequently, genetic variability in ACE2 gene has been suggested to contribute to the variable clinical manifestations in COVID-19. Many of those genetic variations result in missense variants within the amino acid sequence of ACE2. The potential effects of those variations on binding to the spike protein have been speculated and, in some cases, demonstrated experimentally. However, their effects on ACE2 protein folding, trafficking and subcellular targeting have not been established.\u003c/jats:p\u003e\u003c/jats:sec\u003e\u003cjats:sec\u003e\u003cjats:title\u003eResults\u003c/jats:title\u003e\u003cjats:p\u003eIn this study we aimed to examine the potential effects of 28 missense variants (V801G, D785N, R768W, I753T, L731F, L731I, I727V, N720D, R710H, R708W, S692P, E668K, V658I, N638S, A627V, F592L, G575V, A501T, I468V, M383I, G173S, N159S, N149S, D38E, N33D, K26R, I21T, and S19P) distributed across the ACE2 receptor domains on its subcellular trafficking and targeting through combinatorial approach involving in silico analysis and experimental subcellular localization analysis. Our data show that none of the studied missense variants (including 3 variants predicted to be deleterious R768W, G575V, and G173S) has a significant effect on ACE2 intracellular trafficking and subcellular targeting to the plasma membrane.\u003c/jats:p\u003e\u003c/jats:sec\u003e\u003cjats:sec\u003e\u003cjats:title\u003eConclusion\u003c/jats:title\u003e\u003cjats:p\u003eAlthough the selected missense variants display no significant change in ACE2 trafficking and subcellular localization, this does not rule out their effect on viral susceptibility and severity. Further studies are required to investigate the effect of ACE2 variants on its expression, binding, and internalization which might explain the variable clinical manifestations associated with the infection.\u003c/jats:p\u003e\u003c/jats:sec\u003e",
  "alternative-id": [
    "411"
  ],
  "article-number": "35",
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "10 February 2022"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 2,
      "value": "1 July 2022"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 3,
      "value": "2 September 2022"
    },
    {
      "group": {
        "label": "Declarations",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1
    },
    {
      "group": {
        "label": "Ethics approval and consent to participate",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "Not applicable."
    },
    {
      "group": {
        "label": "Consent for publication",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 3,
      "value": "Not applicable."
    },
    {
      "group": {
        "label": "Competing interests",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 4,
      "value": "The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be constructed as a potential conflict of interest."
    }
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Badawi",
      "given": "Sally",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Mohamed",
      "given": "Feda E.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Alkhofash",
      "given": "Nesreen R.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "John",
      "given": "Anne",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Ali",
      "given": "Amanat",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Ali",
      "given": "Bassam R.",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Human Genomics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2022,
        9,
        2
      ]
    ],
    "date-time": "2022-09-02T14:03:27Z",
    "timestamp": 1662127407000
  },
  "deposited": {
    "date-parts": [
      [
        2023,
        11,
        26
      ]
    ],
    "date-time": "2023-11-26T14:26:14Z",
    "timestamp": 1701008774000
  },
  "funder": [
    {
      "award": [
        "AARE19-086, 21M136"
      ],
      "name": "Abu Dhabi ASPIRE Award for Research Excellence"
    }
  ],
  "indexed": {
    "date-parts": [
      [
        2024,
        4,
        29
      ]
    ],
    "date-time": "2024-04-29T05:49:20Z",
    "timestamp": 1714369760366
  },
  "is-referenced-by-count": 5,
  "issn-type": [
    {
      "type": "electronic",
      "value": "1479-7364"
    }
  ],
  "issue": "1",
  "issued": {
    "date-parts": [
      [
        2022,
        9,
        2
      ]
    ]
  },
  "journal-issue": {
    "issue": "1",
    "published-online": {
      "date-parts": [
        [
          2022,
          12
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2022,
            9,
            2
          ]
        ],
        "date-time": "2022-09-02T00:00:00Z",
        "timestamp": 1662076800000
      }
    },
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2022,
            9,
            2
          ]
        ],
        "date-time": "2022-09-02T00:00:00Z",
        "timestamp": 1662076800000
      }
    }
  ],
  "link": [
    {
      "URL": "https://link.springer.com/content/pdf/10.1186/s40246-022-00411-1.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/article/10.1186/s40246-022-00411-1/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/content/pdf/10.1186/s40246-022-00411-1.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "prefix": "10.1186",
  "published": {
    "date-parts": [
      [
        2022,
        9,
        2
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2022,
        9,
        2
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1186/s40246-021-00304-9",
      "author": "S Badawi",
      "doi-asserted-by": "publisher",
      "first-page": "8",
      "issue": "1",
      "journal-title": "Hum Genomics",
      "key": "411_CR1",
      "unstructured": "Badawi S, Ali BR. ACE2 nascence, trafficking, and SARS-CoV-2 pathogenesis: the saga continues. Hum Genomics. 2021;15(1):8.",
      "volume": "15",
      "year": "2021"
    },
    {
      "DOI": "10.1001/jama.2020.2565",
      "author": "Y Bai",
      "doi-asserted-by": "publisher",
      "first-page": "1406",
      "issue": "14",
      "journal-title": "JAMA",
      "key": "411_CR2",
      "unstructured": "Bai Y, Yao L, Wei T, Tian F, Jin DY, Chen L, et al. Presumed asymptomatic carrier transmission of COVID-19. JAMA. 2020;323(14):1406–7.",
      "volume": "323",
      "year": "2020"
    },
    {
      "DOI": "10.1016/j.cmi.2020.04.012",
      "author": "J Zhang",
      "doi-asserted-by": "publisher",
      "first-page": "767",
      "issue": "6",
      "journal-title": "Clin Microbiol Infect",
      "key": "411_CR3",
      "unstructured": "Zhang J, Wang X, Jia X, Li J, Hu K, Chen G, et al. Risk factors for disease severity, unimprovement, and mortality in COVID-19 patients in Wuhan, China. Clin Microbiol Infect. 2020;26(6):767–72.",
      "volume": "26",
      "year": "2020"
    },
    {
      "DOI": "10.1001/jama.2020.6775",
      "author": "S Richardson",
      "doi-asserted-by": "publisher",
      "first-page": "2052",
      "issue": "20",
      "journal-title": "JAMA",
      "key": "411_CR4",
      "unstructured": "Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020;323(20):2052–9.",
      "volume": "323",
      "year": "2020"
    },
    {
      "DOI": "10.1016/j.mayocp.2020.11.024",
      "author": "NL Pereira",
      "doi-asserted-by": "publisher",
      "first-page": "446",
      "issue": "2",
      "journal-title": "Mayo Clin Proc",
      "key": "411_CR5",
      "unstructured": "Pereira NL, Ahmad F, Byku M, Cummins NW, Morris AA, Owens A, et al. COVID-19: understanding inter-individual variability and implications for precision medicine. Mayo Clin Proc. 2021;96(2):446–63.",
      "volume": "96",
      "year": "2021"
    },
    {
      "DOI": "10.1038/s42003-021-02030-3",
      "author": "K Suryamohan",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "issue": "1",
      "journal-title": "Commun Biol",
      "key": "411_CR6",
      "unstructured": "Suryamohan K, Diwanji D, Stawiski EW, Gupta R, Miersch S, Liu J, et al. Human ACE2 receptor polymorphisms and altered susceptibility to SARS-CoV-2. Commun Biol. 2021;4(1):1–11.",
      "volume": "4",
      "year": "2021"
    },
    {
      "DOI": "10.1165/rcmb.2020-0322PS",
      "author": "H Jia",
      "doi-asserted-by": "publisher",
      "first-page": "416",
      "issue": "4",
      "journal-title": "Am J Respir Cell Mol Biol",
      "key": "411_CR7",
      "unstructured": "Jia H, Neptune E, Cui H. Targeting ACE2 for COVID-19 therapy: opportunities and challenges. Am J Respir Cell Mol Biol. 2021;64(4):416–25.",
      "volume": "64",
      "year": "2021"
    },
    {
      "DOI": "10.1038/s41421-020-0147-1",
      "author": "Y Cao",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "issue": "1",
      "journal-title": "Cell Discov",
      "key": "411_CR8",
      "unstructured": "Cao Y, Li L, Feng Z, Wan S, Huang P, Sun X, et al. Comparative genetic analysis of the novel coronavirus (2019-nCoV/SARS-CoV-2) receptor ACE2 in different populations. Cell Discov. 2020;6(1):1–4.",
      "volume": "6",
      "year": "2020"
    },
    {
      "DOI": "10.1038/s41431-020-0691-z",
      "author": "E Benetti",
      "doi-asserted-by": "publisher",
      "first-page": "1602",
      "issue": "11",
      "journal-title": "Eur J Hum Genet",
      "key": "411_CR9",
      "unstructured": "Benetti E, Tita R, Spiga O, Ciolfi A, Birolo G, Bruselles A, et al. ACE2 gene variants may underlie interindividual variability and susceptibility to COVID-19 in the Italian population. Eur J Hum Genet. 2020;28(11):1602–14.",
      "volume": "28",
      "year": "2020"
    },
    {
      "DOI": "10.1186/s40246-020-00279-z",
      "author": "A Novelli",
      "doi-asserted-by": "publisher",
      "first-page": "29",
      "issue": "1",
      "journal-title": "Hum Genomics",
      "key": "411_CR10",
      "unstructured": "Novelli A, Biancolella M, Borgiani P, Cocciadiferro D, Colona VL, D’Apice MR, et al. Analysis of ACE2 genetic variants in 131 Italian SARS-CoV-2-positive patients. Hum Genomics. 2020;14(1):29.",
      "volume": "14",
      "year": "2020"
    },
    {
      "DOI": "10.1016/j.virusres.2014.03.010",
      "author": "X Liu",
      "doi-asserted-by": "publisher",
      "first-page": "64",
      "issue": "185",
      "journal-title": "Virus Res",
      "key": "411_CR11",
      "unstructured": "Liu X, Yang N, Tang J, Liu S, Luo D, Duan Q, et al. Downregulation of angiotensin-converting enzyme 2 by the neuraminidase protein of influenza A (H1N1) virus. Virus Res. 2014;24(185):64–71.",
      "volume": "24",
      "year": "2014"
    },
    {
      "author": "A Saih",
      "first-page": "e6685840",
      "issue": "2021",
      "journal-title": "BioMed Res Int",
      "key": "411_CR12",
      "unstructured": "Saih A, Baba H, Bouqdayr M, Ghazal H, Hamdi S, Kettani A, et al. In Silico analysis of high-risk missense variants in human ACE2 gene and susceptibility to SARS-CoV-2 infection. BioMed Res Int. 2021;9(2021):e6685840.",
      "volume": "9",
      "year": "2021"
    },
    {
      "DOI": "10.3389/fcimb.2021.753721",
      "author": "F Chen",
      "doi-asserted-by": "publisher",
      "journal-title": "Front Cell Infect Microbiol",
      "key": "411_CR13",
      "unstructured": "Chen F, Zhang Y, Li X, Li W, Liu X, Xue X. The impact of ACE2 polymorphisms on COVID-19 disease: susceptibility, severity, and therapy. Front Cell Infect Microbiol. 2021. https://doi.org/10.3389/fcimb.2021.753721.",
      "year": "2021"
    },
    {
      "DOI": "10.1002/2211-5463.12740",
      "author": "P Kizhakkedath",
      "doi-asserted-by": "publisher",
      "first-page": "1994",
      "issue": "11",
      "journal-title": "FEBS Open Bio",
      "key": "411_CR14",
      "unstructured": "Kizhakkedath P, John A, Al-Sawafi BK, Al-Gazali L, Ali BR. Endoplasmic reticulum quality control of LDLR variants associated with familial hypercholesterolemia. FEBS Open Bio. 2019;9(11):1994–2005.",
      "volume": "9",
      "year": "2019"
    },
    {
      "DOI": "10.3390/ph13040075",
      "author": "R Fukuda",
      "doi-asserted-by": "publisher",
      "first-page": "75",
      "issue": "4",
      "journal-title": "Pharmaceuticals",
      "key": "411_CR15",
      "unstructured": "Fukuda R, Okiyoneda T. Cystic fibrosis transmembrane conductance regulator (CFTR) ubiquitylation as a novel pharmaceutical target for cystic fibrosis. Pharmaceuticals. 2020;13(4):75.",
      "volume": "13",
      "year": "2020"
    },
    {
      "DOI": "10.1007/s00439-020-02153-3",
      "author": "FE Mohamed",
      "doi-asserted-by": "publisher",
      "first-page": "657",
      "issue": "5",
      "journal-title": "Hum Genet",
      "key": "411_CR16",
      "unstructured": "Mohamed FE, Al Sorkhy M, Ghattas MA, Al-Gazali L, Al-Dirbashi O, Al-Jasmi F, et al. The pharmacological chaperone N-n-butyl-deoxygalactonojirimycin enhances β-galactosidase processing and activity in fibroblasts of a patient with infantile GM1-gangliosidosis. Hum Genet. 2020;139(5):657–73.",
      "volume": "139",
      "year": "2020"
    },
    {
      "DOI": "10.1101/cshperspect.a033928",
      "author": "PG Needham",
      "doi-asserted-by": "publisher",
      "first-page": "a033928",
      "issue": "8",
      "journal-title": "Cold Spring Harb Perspect Biol",
      "key": "411_CR17",
      "unstructured": "Needham PG, Guerriero CJ, Brodsky JL. Chaperoning endoplasmic reticulum-associated degradation (ERAD) and protein conformational diseases. Cold Spring Harb Perspect Biol. 2019;11(8):a033928.",
      "volume": "11",
      "year": "2019"
    },
    {
      "DOI": "10.3389/fmolb.2020.575608",
      "author": "N Gariballa",
      "doi-asserted-by": "publisher",
      "first-page": "575608",
      "journal-title": "Front Mol Biosci",
      "key": "411_CR18",
      "unstructured": "Gariballa N, Ali BR. Endoplasmic reticulum associated protein degradation (ERAD) in the pathology of diseases related to TGFβ signaling pathway: future therapeutic perspectives. Front Mol Biosci. 2020;7:575608.",
      "volume": "7",
      "year": "2020"
    },
    {
      "DOI": "10.1371/journal.pone.0020854",
      "author": "RM de Oliveira",
      "doi-asserted-by": "publisher",
      "first-page": "e20854",
      "issue": "6",
      "journal-title": "PLoS ONE",
      "key": "411_CR19",
      "unstructured": "de Oliveira RM, Marijanovic Z, Carvalho F, Miltényi GM, Matos JE, Tenreiro S, et al. Impaired proteostasis contributes to renal tubular dysgenesis. PLoS ONE. 2011;6(6):e20854.",
      "volume": "6",
      "year": "2011"
    },
    {
      "DOI": "10.1038/nprot.2015.123",
      "author": "R Vaser",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "issue": "1",
      "journal-title": "Nat Protoc",
      "key": "411_CR20",
      "unstructured": "Vaser R, Adusumalli S, Leng SN, Sikic M, Ng PC. SIFT missense predictions for genomes. Nat Protoc. 2016;11(1):1–9.",
      "volume": "11",
      "year": "2016"
    },
    {
      "DOI": "10.1038/nmeth0410-248",
      "author": "IA Adzhubei",
      "doi-asserted-by": "publisher",
      "first-page": "248",
      "issue": "4",
      "journal-title": "Nat Methods",
      "key": "411_CR21",
      "unstructured": "Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, et al. A method and server for predicting damaging missense mutations. Nat Methods. 2010;7(4):248–9.",
      "volume": "7",
      "year": "2010"
    },
    {
      "DOI": "10.1371/journal.pone.0046688",
      "author": "Y Choi",
      "doi-asserted-by": "publisher",
      "first-page": "e46688",
      "issue": "10",
      "journal-title": "PLoS ONE",
      "key": "411_CR22",
      "unstructured": "Choi Y, Sims GE, Murphy S, Miller JR, Chan AP. Predicting the functional effect of amino acid substitutions and Indels. PLoS ONE. 2012;7(10):e46688.",
      "volume": "7",
      "year": "2012"
    },
    {
      "DOI": "10.1038/nmeth.2890",
      "author": "JM Schwarz",
      "doi-asserted-by": "publisher",
      "first-page": "361",
      "issue": "4",
      "journal-title": "Nat Methods",
      "key": "411_CR23",
      "unstructured": "Schwarz JM, Cooper DN, Schuelke M, Seelow D. MutationTaster2: mutation prediction for the deep-sequencing age. Nat Methods. 2014;11(4):361–2.",
      "volume": "11",
      "year": "2014"
    },
    {
      "DOI": "10.1093/nar/gki375",
      "author": "E Capriotti",
      "doi-asserted-by": "publisher",
      "first-page": "W306",
      "issue": "33",
      "journal-title": "Nucl Acids Res.",
      "key": "411_CR24",
      "unstructured": "Capriotti E, Fariselli P, Casadio R. I-Mutant20: predicting stability changes upon mutation from the protein sequence or structure. Nucl Acids Res. 2005;1(33):W306-310.",
      "volume": "1",
      "year": "2005"
    },
    {
      "DOI": "10.1186/1471-2105-9-40",
      "author": "Y Zhang",
      "doi-asserted-by": "publisher",
      "first-page": "40",
      "issue": "9",
      "journal-title": "BMC Bioinform",
      "key": "411_CR25",
      "unstructured": "Zhang Y. I-TASSER server for protein 3D structure prediction. BMC Bioinform. 2008;23(9):40.",
      "volume": "23",
      "year": "2008"
    },
    {
      "DOI": "10.1093/nar/gky427",
      "author": "A Waterhouse",
      "doi-asserted-by": "publisher",
      "first-page": "W296",
      "issue": "W1",
      "journal-title": "Nucleic Acids Res",
      "key": "411_CR26",
      "unstructured": "Waterhouse A, Bertoni M, Bienert S, Studer G, Tauriello G, Gumienny R, et al. SWISS-MODEL: homology modelling of protein structures and complexes. Nucleic Acids Res. 2018;46(W1):W296-303.",
      "volume": "46",
      "year": "2018"
    },
    {
      "DOI": "10.1093/hmg/ddn354",
      "author": "AN Hume",
      "doi-asserted-by": "publisher",
      "first-page": "267",
      "issue": "2",
      "journal-title": "Hum Mol Genet",
      "key": "411_CR27",
      "unstructured": "Hume AN, Buttgereit J, Al-Awadhi AM, Al-Suwaidi SS, John A, Bader M, et al. Defective cellular trafficking of missense NPR-B mutants is the major mechanism underlying acromesomelic dysplasia-type Maroteaux. Hum Mol Genet. 2009;18(2):267–77.",
      "volume": "18",
      "year": "2009"
    },
    {
      "DOI": "10.1038/nmeth.2089",
      "author": "CA Schneider",
      "doi-asserted-by": "publisher",
      "first-page": "671",
      "issue": "7",
      "journal-title": "Nat Methods",
      "key": "411_CR28",
      "unstructured": "Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of Image Analysis. Nat Methods. 2012;9(7):671–5.",
      "volume": "9",
      "year": "2012"
    },
    {
      "DOI": "10.1128/Spectrum.01199-21",
      "author": "R Rowland",
      "doi-asserted-by": "publisher",
      "first-page": "e01199",
      "issue": "2",
      "journal-title": "Microbiol Spectr.",
      "key": "411_CR29",
      "unstructured": "Rowland R, Brandariz-Nuñez A. Analysis of the role of N-linked glycosylation in cell surface expression, function, and binding properties of SARS-CoV-2 receptor ACE2. Microbiol Spectr. 2021;9(2):e01199-21.",
      "volume": "9",
      "year": "2021"
    },
    {
      "DOI": "10.1073/pnas.2100425118",
      "author": "AR Mehdipour",
      "doi-asserted-by": "publisher",
      "first-page": "e2100425118",
      "issue": "19",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "411_CR30",
      "unstructured": "Mehdipour AR, Hummer G. Dual nature of human ACE2 glycosylation in binding to SARS-CoV-2 spike. Proc Natl Acad Sci USA. 2021;118(19):e2100425118.",
      "volume": "118",
      "year": "2021"
    },
    {
      "DOI": "10.1016/j.heliyon.2021.e06133",
      "author": "F Al-Mulla",
      "doi-asserted-by": "publisher",
      "first-page": "e06133",
      "issue": "2",
      "journal-title": "Heliyon",
      "key": "411_CR31",
      "unstructured": "Al-Mulla F, Mohammad A, Al Madhoun A, Haddad D, Ali H, Eaaswarkhanth M, et al. ACE2 and FURIN variants are potential predictors of SARS-CoV-2 outcome: a time to implement precision medicine against COVID-19. Heliyon. 2021;7(2):e06133.",
      "volume": "7",
      "year": "2021"
    },
    {
      "DOI": "10.1038/s41435-020-0107-7",
      "author": "L Ortiz-Fernández",
      "doi-asserted-by": "publisher",
      "first-page": "269",
      "issue": "4",
      "journal-title": "Genes Immun",
      "key": "411_CR32",
      "unstructured": "Ortiz-Fernández L, Sawalha AH. Genetic variability in the expression of the SARS-CoV-2 host cell entry factors across populations. Genes Immun. 2020;21(4):269–72.",
      "volume": "21",
      "year": "2020"
    },
    {
      "DOI": "10.1186/s12916-020-01673-z",
      "author": "Y Hou",
      "doi-asserted-by": "publisher",
      "first-page": "216",
      "issue": "18",
      "journal-title": "BMC Med",
      "key": "411_CR33",
      "unstructured": "Hou Y, Zhao J, Martin W, Kallianpur A, Chung MK, Jehi L, et al. New insights into genetic susceptibility of COVID-19: an ACE2 and TMPRSS2 polymorphism analysis. BMC Med. 2020;15(18):216.",
      "volume": "15",
      "year": "2020"
    },
    {
      "DOI": "10.1128/JVI.01492-21",
      "author": "W Ren",
      "doi-asserted-by": "publisher",
      "first-page": "e0149221",
      "issue": "1",
      "journal-title": "J Virol",
      "key": "411_CR34",
      "unstructured": "Ren W, Zhu Y, Lan J, Chen H, Wang Y, Shi H, et al. Susceptibilities of human ACE2 genetic variants in coronavirus infection. J Virol. 2022;96(1):e0149221.",
      "volume": "96",
      "year": "2022"
    },
    {
      "DOI": "10.1038/s41597-020-00652-6",
      "author": "M Sorokina",
      "doi-asserted-by": "publisher",
      "first-page": "309",
      "issue": "1",
      "journal-title": "Sci Data",
      "key": "411_CR35",
      "unstructured": "Sorokina M, Teixeira J, Barrera-Vilarmau S, Paschke R, Papasotiriou I, Rodrigues JPGLM, et al. Structural models of human ACE2 variants with SARS-CoV-2 Spike protein for structure-based drug design. Sci Data. 2020;7(1):309.",
      "volume": "7",
      "year": "2020"
    },
    {
      "DOI": "10.1371/journal.pone.0251585",
      "author": "P Heinzelman",
      "doi-asserted-by": "publisher",
      "first-page": "e0251585",
      "issue": "5",
      "journal-title": "PLoS ONE",
      "key": "411_CR36",
      "unstructured": "Heinzelman P, Romero PA. Discovery of human ACE2 variants with altered recognition by the SARS-CoV-2 spike protein. PLoS ONE. 2021;16(5):e0251585.",
      "volume": "16",
      "year": "2021"
    },
    {
      "DOI": "10.1038/s41586-020-2308-7",
      "author": "KJ Karczewski",
      "doi-asserted-by": "publisher",
      "first-page": "434",
      "issue": "7809",
      "journal-title": "Nature",
      "key": "411_CR37",
      "unstructured": "Karczewski KJ, Francioli LC, Tiao G, Cummings BB, Alföldi J, Wang Q, et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature. 2020;581(7809):434–43.",
      "volume": "581",
      "year": "2020"
    },
    {
      "DOI": "10.1038/s41467-020-18880-0",
      "author": "H Jia",
      "doi-asserted-by": "publisher",
      "first-page": "5165",
      "issue": "1",
      "journal-title": "Nat Commun",
      "key": "411_CR38",
      "unstructured": "Jia H, Yue X, Lazartigues E. ACE2 mouse models: a toolbox for cardiovascular and pulmonary research. Nat Commun. 2020;11(1):5165.",
      "volume": "11",
      "year": "2020"
    },
    {
      "DOI": "10.1038/s41598-021-95308-9",
      "author": "EJ Sherman",
      "doi-asserted-by": "publisher",
      "first-page": "15900",
      "issue": "1",
      "journal-title": "Sci Rep",
      "key": "411_CR39",
      "unstructured": "Sherman EJ, Emmer BT. ACE2 protein expression within isogenic cell lines is heterogeneous and associated with distinct transcriptomes. Sci Rep. 2021;11(1):15900.",
      "volume": "11",
      "year": "2021"
    },
    {
      "DOI": "10.1371/journal.ppat.1009715",
      "author": "N Shukla",
      "doi-asserted-by": "publisher",
      "first-page": "e1009715",
      "issue": "7",
      "journal-title": "PLOS Pathog",
      "key": "411_CR40",
      "unstructured": "Shukla N, Roelle SM, Suzart VG, Bruchez AM, Matreyek KA. Mutants of human ACE2 differentially promote SARS-CoV and SARS-CoV-2 spike mediated infection. PLOS Pathog. 2021;17(7):e1009715.",
      "volume": "17",
      "year": "2021"
    },
    {
      "DOI": "10.1093/molbev/msab060",
      "author": "MJ Bhattacharjee",
      "doi-asserted-by": "publisher",
      "first-page": "2715",
      "issue": "7",
      "journal-title": "Mol Biol Evol",
      "key": "411_CR41",
      "unstructured": "Bhattacharjee MJ, Lin JJ, Chang CY, Chiou YT, Li TN, Tai CW, et al. Identifying primate ACE2 variants that confer resistance to SARS-CoV-2. Mol Biol Evol. 2021;38(7):2715–31.",
      "volume": "38",
      "year": "2021"
    },
    {
      "DOI": "10.1371/journal.pcbi.1009922",
      "author": "SA MacGowan",
      "doi-asserted-by": "publisher",
      "first-page": "e1009922",
      "issue": "3",
      "journal-title": "PLoS Comput Biol",
      "key": "411_CR42",
      "unstructured": "MacGowan SA, Barton MI, Kutuzov M, Dushek O, van der Merwe PA, Barton GJ. Missense variants in human ACE2 strongly affect binding to SARS-CoV-2 Spike providing a mechanism for ACE2 mediated genetic risk in Covid-19: case study in affinity predictions of interface variants. PLoS Comput Biol. 2022;18(3):e1009922.",
      "volume": "18",
      "year": "2022"
    },
    {
      "DOI": "10.1126/science.abc0870",
      "author": "KK Chan",
      "doi-asserted-by": "publisher",
      "first-page": "1261",
      "issue": "6508",
      "journal-title": "Science",
      "key": "411_CR43",
      "unstructured": "Chan KK, Dorosky D, Sharma P, Abbasi SA, Dye JM, Kranz DM, et al. Engineering human ACE2 to optimize binding to the spike protein of SARS coronavirus 2. Science. 2020;369(6508):1261–5.",
      "volume": "369",
      "year": "2020"
    },
    {
      "DOI": "10.7554/eLife.70658",
      "author": "MI Barton",
      "doi-asserted-by": "publisher",
      "first-page": "e70658",
      "journal-title": "eLife.",
      "key": "411_CR44",
      "unstructured": "Barton MI, MacGowan SA, Kutuzov MA, Dushek O, Barton GJ, Van der Merwe PA. Effects of common mutations in the SARS-CoV-2 Spike RBD and its ligand, the human ACE2 receptor on binding affinity and kinetics. eLife. 2021;10:e70658.",
      "volume": "10",
      "year": "2021"
    },
    {
      "DOI": "10.1016/j.lfs.2020.118219",
      "author": "A Mohammad",
      "doi-asserted-by": "publisher",
      "first-page": "118219",
      "issue": "259",
      "journal-title": "Life Sci",
      "key": "411_CR45",
      "unstructured": "Mohammad A, Marafie SK, Alshawaf E, Abu-Farha M, Abubaker J, Al-Mulla F. Structural analysis of ACE2 variant N720D demonstrates a higher binding affinity to TMPRSS2. Life Sci. 2020;15(259):118219.",
      "volume": "15",
      "year": "2020"
    },
    {
      "DOI": "10.1021/acs.jproteome.0c00348",
      "author": "H Hadi-Alijanvand",
      "doi-asserted-by": "publisher",
      "first-page": "4609",
      "issue": "11",
      "journal-title": "J Proteome Res.",
      "key": "411_CR46",
      "unstructured": "Hadi-Alijanvand H, Rouhani M. Studying the effects of ACE2 mutations on the stability, dynamics, and dissociation process of SARS-CoV-2 S1/hACE2 complexes. J Proteome Res. 2020;19(11):4609–23.",
      "volume": "19",
      "year": "2020"
    },
    {
      "DOI": "10.1128/JVI.00253-07",
      "author": "Y Inoue",
      "doi-asserted-by": "publisher",
      "first-page": "8722",
      "issue": "16",
      "journal-title": "J Virol",
      "key": "411_CR47",
      "unstructured": "Inoue Y, Tanaka N, Tanaka Y, Inoue S, Morita K, Zhuang M, et al. Clathrin-dependent entry of severe acute respiratory syndrome coronavirus into target cells expressing ACE2 with the cytoplasmic tail deleted. J Virol. 2007;81(16):8722–9.",
      "volume": "81",
      "year": "2007"
    },
    {
      "DOI": "10.3390/cells10071814",
      "author": "T Karthika",
      "doi-asserted-by": "publisher",
      "first-page": "1814",
      "issue": "7",
      "journal-title": "Cells",
      "key": "411_CR48",
      "unstructured": "Karthika T, Joseph J, Das VRA, Nair N, Charulekha P, Roji MD, et al. SARS-CoV-2 cellular entry is independent of the ACE2 cytoplasmic domain signaling. Cells. 2021;10(7):1814.",
      "volume": "10",
      "year": "2021"
    },
    {
      "DOI": "10.1155/2015/505294",
      "author": "R Singh",
      "doi-asserted-by": "publisher",
      "first-page": "505294",
      "journal-title": "Int J Cell Biol",
      "key": "411_CR49",
      "unstructured": "Singh R, Almutairi MM, Pacheco-Andrade R, Almiahuob MYM, Di Fulvio M. Impact of hybrid and complex N-glycans on cell surface targeting of the endogenous chloride cotransporter Slc12a2. Int J Cell Biol. 2015;2015:505294.",
      "volume": "2015",
      "year": "2015"
    },
    {
      "DOI": "10.1016/j.bbamcr.2013.01.018",
      "author": "TY Weng",
      "doi-asserted-by": "publisher",
      "first-page": "1133",
      "issue": "5",
      "journal-title": "Biochim Biophys Acta",
      "key": "411_CR50",
      "unstructured": "Weng TY, Chiu WT, Liu HS, Cheng HC, Shen MR, Mount DB, et al. Glycosylation regulates the function and membrane localization of KCC4. Biochim Biophys Acta. 2013;1833(5):1133–46.",
      "volume": "1833",
      "year": "2013"
    },
    {
      "DOI": "10.1038/s41598-020-61370-y",
      "author": "T Wang",
      "doi-asserted-by": "publisher",
      "first-page": "4429",
      "issue": "1",
      "journal-title": "Sci Rep",
      "key": "411_CR51",
      "unstructured": "Wang T, Nakagawa S, Miyake T, Setsu G, Kunisue S, Goto K, et al. Identification and functional characterisation of N-linked glycosylation of the orphan G protein-coupled receptor Gpr176. Sci Rep. 2020;10(1):4429.",
      "volume": "10",
      "year": "2020"
    },
    {
      "DOI": "10.1016/j.chom.2020.08.004",
      "author": "P Zhao",
      "doi-asserted-by": "publisher",
      "first-page": "586",
      "issue": "4",
      "journal-title": "Cell Host Microbe",
      "key": "411_CR52",
      "unstructured": "Zhao P, Praissman JL, Grant OC, Cai Y, Xiao T, Rosenbalm KE, et al. Virus-receptor interactions of glycosylated SARS-CoV-2 spike and human ACE2 receptor. Cell Host Microbe. 2020;28(4):586-601.e6.",
      "volume": "28",
      "year": "2020"
    },
    {
      "DOI": "10.36519/idcm.2021.42",
      "author": "S Beyerstedt",
      "doi-asserted-by": "crossref",
      "first-page": "1",
      "journal-title": "Eur J Clin Microbiol Infect Dis",
      "key": "411_CR53",
      "unstructured": "Beyerstedt S, Casaro EB, Rangel ÉB. COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection. Eur J Clin Microbiol Infect Dis. 2021;3:1–15.",
      "volume": "3",
      "year": "2021"
    },
    {
      "DOI": "10.3390/ijms21103474",
      "author": "D Gemmati",
      "doi-asserted-by": "publisher",
      "first-page": "3474",
      "issue": "10",
      "journal-title": "Int J Mol Sci.",
      "key": "411_CR54",
      "unstructured": "Gemmati D, Bramanti B, Serino ML, Secchiero P, Zauli G, Tisato V. COVID-19 and individual genetic susceptibility/receptivity: role of ACE1/ACE2 genes, immunity, inflammation and coagulation: might the double X-chromosome in females be protective against SARS-CoV-2 compared to the single X-chromosome in males? Int J Mol Sci. 2020;21(10):3474.",
      "volume": "21",
      "year": "2020"
    },
    {
      "DOI": "10.1111/acel.13168",
      "author": "J Chen",
      "doi-asserted-by": "publisher",
      "first-page": "e13168",
      "issue": "7",
      "journal-title": "Aging Cell",
      "key": "411_CR55",
      "unstructured": "Chen J, Jiang Q, Xia X, Liu K, Yu Z, Tao W, et al. Individual variation of the SARS-CoV-2 receptor ACE2 gene expression and regulation. Aging Cell. 2020;19(7):e13168.",
      "volume": "19",
      "year": "2020"
    },
    {
      "DOI": "10.1002/cbf.3648",
      "author": "RS Lima",
      "doi-asserted-by": "publisher",
      "journal-title": "Cell Biochem Funct",
      "key": "411_CR56",
      "unstructured": "Lima RS, Rocha LPC, Moreira PR. Genetic and epigenetic control of ACE2 expression and its possible role in COVID-19. Cell Biochem Funct. 2021. https://doi.org/10.1002/cbf.3648.",
      "year": "2021"
    },
    {
      "DOI": "10.1186/s40246-021-00326-3",
      "author": "G Novelli",
      "doi-asserted-by": "publisher",
      "first-page": "27",
      "issue": "1",
      "journal-title": "Hum Genomics",
      "key": "411_CR57",
      "unstructured": "Novelli G, Biancolella M, Mehrian-Shai R, Colona VL, Brito AF, Grubaugh ND, et al. COVID-19 one year into the pandemic: from genetics and genomics to therapy, vaccination, and policy. Hum Genomics. 2021;15(1):27.",
      "volume": "15",
      "year": "2021"
    },
    {
      "DOI": "10.14336/AD.2021.0805",
      "author": "M Zheng",
      "doi-asserted-by": "crossref",
      "first-page": "360",
      "issue": "2",
      "journal-title": "Aging Dis",
      "key": "411_CR58",
      "unstructured": "Zheng M. ACE2 and COVID-19 susceptibility and severity. Aging Dis. 2022;13(2):360.",
      "volume": "13",
      "year": "2022"
    }
  ],
  "reference-count": 58,
  "references-count": 58,
  "resource": {
    "primary": {
      "URL": "https://humgenomics.biomedcentral.com/articles/10.1186/s40246-022-00411-1"
    }
  },
  "score": 0,
  "short-container-title": [
    "Hum Genomics"
  ],
  "source": "Crossref",
  "title": [
    "Characterization of ACE2 naturally occurring missense variants: impact on subcellular localization and trafficking"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "16"
}